Can Cystic Fibrosis Patients Finally Catch a Breath With Lumacaftor/Ivacaftor?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Can Cystic Fibrosis Patients Finally Catch a Breath With Lumacaftor/Ivacaftor?

Published:2016-11-23 Issue:1 Volume:101 Page:130-141
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Schneider EK¹,Reyes-Ortega F¹,Li J¹²,Velkov T¹

Affiliation:

1. Drug Delivery, Disposition and Dynamics; Monash Institute of Pharmaceutical Sciences; Monash University; Parkville Victoria Australia

2. Monash Biomedicine Discovery Institute, Department of Microbiology; Monash University; Clayton Victoria Australia

Funder

National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference74 articles.

1. Drug-drug plasma protein binding interactions of ivacaftor;Schneider;J Mol Recog.,2015

2. The prevalence of cystic fibrosis in the European Union;Farrell;J Cyst Fibros.,2008

3. Heterogeneity in the severity of cystic fibrosis and the role of CFTR gene mutations;Dean;Hum Genet.,1994

4. CFTR expression and organ damage in cystic fibrosis;Tizzano;Ann Intern Med.,1995

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential distribution of ivacaftor and its metabolites in plasma and human airway epithelia;Pulmonary Pharmacology & Therapeutics;2024-09

2. A rapid LC-MS/MS method for the simultaneous quantification of ivacaftor, lumacaftor, elexacaftor, tezacaftor, hexyl-methyl ivacaftor and ivacaftor carboxylate in human plasma;Journal of Pharmaceutical and Biomedical Analysis;2024-09

3. The role of CFTR in the eye, and the effect of early highly effective modulator treatment for cystic fibrosis on eye health;Progress in Retinal and Eye Research;2024-09

4. Dried Blood Spot Method Development and Clinical Validation for the Analysis of Elexacaftor, Elexacaftor-M23, Tezacaftor, Tezacaftor-M1, Ivacaftor, Ivacaftor Carboxylate, and Hydroxymethyl Ivacaftor Using LC-MS/MS;Therapeutic Drug Monitoring;2024-08-27

5. Recommended Tool Compounds for Modifying the Cystic Fibrosis Transmembrane Conductance Regulator Channel Variants;ACS Pharmacology & Translational Science;2024-03-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3